- Home
- IQV
as 05-20-2024 12:34pm EST
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
| Founded: | 1982 | Country: | United States |
| Employees: | 87000 | City: | DURHAM |
| Market Cap: | 42.1B | IPO Year: | 2013 |
| Target Price: | $257.57 | AVG Volume (30 days): | 883.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 15 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 7.31 | EPS Growth: | 31.47 |
| 52 Week Low/High: | $167.42 - $261.73 | Next Earning Date: | 05-02-2024 |
| Revenue: | $15,069,000,000 | Revenue Growth: | 3.97% |
| Revenue Growth (this year): | 4.71% | Revenue Growth (next year): | 7.27% |
Share on Social Networks:
Stock Insider Trading Activity of IQVIA Holdings Inc. (IQV)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BOUSBIB ARI | IQV | See Remarks | Mar 1 '24 | Sell | $250.05 | 16,261 | $4,066,063.05 | 812,169 | SEC Form 4 |
| BOUSBIB ARI | IQV | See Remarks | Mar 1 '24 | Sell | $251.03 | 15,417 | $3,870,129.51 | 796,752 | SEC Form 4 |
| STAUB W RICHARD | IQV | See Remarks | Feb 29 '24 | Sell | $249.08 | 2,068 | $515,097.44 | 15,945 | SEC Form 4 |
| STAUB W RICHARD | IQV | See Remarks | Feb 29 '24 | Sell | $248.33 | 3,062 | $760,386.46 | 18,013 | SEC Form 4 |
| STAUB W RICHARD | IQV | See Remarks | Feb 29 '24 | Sell | $247.33 | 8,970 | $2,218,550.10 | 21,075 | SEC Form 4 |
| Knightly Kevin C | IQV | See Remarks | Feb 28 '24 | Sell | $249.94 | 6,425 | $1,605,864.50 | 7,433 | SEC Form 4 |
| Knightly Kevin C | IQV | See Remarks | Feb 28 '24 | Sell | $250.83 | 2,182 | $547,311.06 | 5,251 | SEC Form 4 |
| Knightly Kevin C | IQV | See Remarks | Feb 16 '24 | Sell | $241.38 | 4,021 | $970,588.98 | 652 | SEC Form 4 |
| Knightly Kevin C | IQV | See Remarks | Feb 16 '24 | Sell | $240.73 | 1,239 | $298,264.47 | 4,673 | SEC Form 4 |
| Knightly Kevin C | IQV | See Remarks | Feb 16 '24 | Sell | $241.23 | 4,867 | $1,174,066.41 | 9,853 | SEC Form 4 |
| Knightly Kevin C | IQV | See Remarks | Feb 16 '24 | Sell | $240.72 | 3,341 | $804,245.52 | 14,720 | SEC Form 4 |
| Sherbet Eric | IQV | See Remarks | Feb 16 '24 | Sell | $241.50 | 1,000 | $241,500.00 | 20,836 | SEC Form 4 |
| Knightly Kevin C | IQV | See Remarks | Dec 1 '23 | Sell | $215.29 | 378 | $81,379.62 | 7,347 | SEC Form 4 |
| Knightly Kevin C | IQV | See Remarks | Dec 1 '23 | Sell | $214.32 | 5,855 | $1,254,843.60 | 7,725 | SEC Form 4 |
| Knightly Kevin C | IQV | See Remarks | Dec 1 '23 | Sell | $213.72 | 6,884 | $1,471,248.48 | 13,580 | SEC Form 4 |
Latest IQVIA Holdings Inc. News
IQV Breaking Stock News: Dive into IQV Ticker-Specific Updates for Smart Investing
Business Wire
6 days ago
U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute
Simply Wall St.
8 days ago
At US$234, Is It Time To Put IQVIA Holdings Inc. (NYSE:IQV) On Your Watch List?
Business Wire
11 days ago
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
MT Newswires
13 days ago
Stifel Adjusts Price Target on IQVIA Holdings to $288 From $294
Zacks
14 days ago
What's in Store for International Money's (IMXI) Q1 Earnings?
Simply Wall St.
14 days ago
Is IQVIA Holdings Inc.'s (NYSE:IQV) ROE Of 21% Impressive?
Insider Monkey
16 days ago
IQVIA Holdings Inc. (NYSE:IQV) Q1 2024 Earnings Call Transcript
Morningstar Research
17 days ago